Market Overview:
The global AIDS Test Kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of HIV/AIDS, growing awareness about HIV/AIDS testing, and technological advancements in AIDS Test Kits. The global AIDS Test Kits market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibody tests, RNA (viral load) tests, and antibody-antigen tests. The antibody test segment is expected to account for the largest share of the global AIDS Test Kits market in 2018 owing to its high usage rates for both screening and diagnosis purposes.
Product Definition:
An AIDS test kit is a medical device used to determine if a person has been infected with the human immunodeficiency virus (HIV), which can cause AIDS. The importance of AIDS test kits is that they allow for early diagnosis and treatment of HIV infection, which can prolong a person's life and reduce the risk of transmitting the virus to others.
Antibody Tests:
Antibody tests are used for the detection of antibodies in the blood. These tests are also known as immunoassays or antibody assays. The test works by detecting an immune response to a particular virus, bacteria, or tumor cell through specific antibodies present in the blood sample. An increase in research and development activities has led to several new product launches which have increased market penetration globally.
RNA (viral load) Test:
The RNA (viral load) test is used to measure the amount of viral RNA in a sample. Viral load testing has been incorporated as an integral part of the standard procedure for diagnosing HIV infection, Hepatitis C virus (HCV), and other viruses causing chronic diseases. The technique measures the amount of viral nucleic acid in a specimen using real-time reverse transcription PCR (RT-PCR).
Application Insights:
The diagnostic centers segment dominated the global AIDS test kits market in 2017. This is attributed to factors such as availability of a large number of testing facilities, high prevalence of HIV and other sexually transmitted diseases (STDs) in this region, and increasing demand for rapid testing services among individuals who have sex with men (OSM). In addition, an increase in the adoption of self-testing products through home use is expected to boost growth over the forecast period.
However, owing to an increase in funding for diagnostics development by government organizations such as PEPFAR and GAVS, along with private foundations like amfAR; there has been a rise in new diagnostic center openings across low-income countries that offer advanced services for HIV/AIDS diagnosis.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of HIV-1 infected individuals and high adoption rate for advanced diagnostic techniques are some factors contributing to the growth of this region. Moreover, increasing government initiatives to control the spread of this disease is also expected to drive demand for these tests over the forecast period. For instance, in September 2016, Public Health England launched an awareness campaign with TV ads and radio spots that encouraged people living with HIV not only to get tested regularly but also take antiretroviral therapy if they test positive for HIV infection (HIV testing services provided by public health England).
Asia Pacific is anticipated to grow at a lucrative rate during the forecast period owing its rapidly growing economy coupled with rising disposable income levels among consumers especially in India & China. Furthermore, increasing investments from international companies such as Abbott are expected will further boost revenue generation from this region during 2018 - 2030 time frame.
Growth Factors:
- Increasing incidence of AIDS and other sexually transmitted diseases (STDs)
- Growing awareness about AIDS and its prevention
- Rising demand for early diagnosis of AIDS and other STDs
- Technological advancements in HIV/AIDS testing kits
- Government initiatives to promote use of HIV/AIDS testing kits
Scope Of The Report
Report Attributes
Report Details
Report Title
AIDS Test Kits Market Research Report
By Type
Antibody Tests, RNA (viral load) Test, Antibody-antigen Test
By Application
Diagnostic Centers, Hospitals, Home Use
By Companies
Roche, Abbott, Bio-Rad, WanTai BioPharm, Beckman Coulter, BD, Kehua, Livzon, Intec, ThermoFisher, Biokit, Nectar Lifesciences, ELITech Group, Chembio Diagnostic Systems, Trinity Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
167
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global AIDS Test Kits Market Report Segments:
The global AIDS Test Kits market is segmented on the basis of:
Types
Antibody Tests, RNA (viral load) Test, Antibody-antigen Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers, Hospitals, Home Use
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott
- Bio-Rad
- WanTai BioPharm
- Beckman Coulter
- BD
- Kehua
- Livzon
- Intec
- ThermoFisher
- Biokit
- Nectar Lifesciences
- ELITech Group
- Chembio Diagnostic Systems
- Trinity Biotech
Highlights of The AIDS Test Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibody Tests
- RNA (viral load) Test
- Antibody-antigen Test
- By Application:
- Diagnostic Centers
- Hospitals
- Home Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the AIDS Test Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
AIDS test kits are a type of medical device used to diagnose HIV infection. They work by detecting the presence of antibodies to HIV in a sample of blood or other bodily fluid.
Some of the key players operating in the aids test kits market are Roche, Abbott, Bio-Rad, WanTai BioPharm, Beckman Coulter, BD, Kehua, Livzon, Intec, ThermoFisher, Biokit, Nectar Lifesciences, ELITech Group, Chembio Diagnostic Systems, Trinity Biotech.
The aids test kits market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 AIDS Test Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 AIDS Test Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 AIDS Test Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the AIDS Test Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global AIDS Test Kits Market Size & Forecast, 2020-2028
4.5.1 AIDS Test Kits Market Size and Y-o-Y Growth
4.5.2 AIDS Test Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibody Tests
5.2.2 RNA (viral load) Test
5.2.3 Antibody-antigen Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostic Centers
6.2.2 Hospitals
6.2.3 Home Use
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global AIDS Test Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 AIDS Test Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibody Tests
9.6.2 RNA (viral load) Test
9.6.3 Antibody-antigen Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostic Centers
9.10.2 Hospitals
9.10.3 Home Use
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibody Tests
10.6.2 RNA (viral load) Test
10.6.3 Antibody-antigen Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostic Centers
10.10.2 Hospitals
10.10.3 Home Use
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibody Tests
11.6.2 RNA (viral load) Test
11.6.3 Antibody-antigen Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostic Centers
11.10.2 Hospitals
11.10.3 Home Use
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibody Tests
12.6.2 RNA (viral load) Test
12.6.3 Antibody-antigen Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostic Centers
12.10.2 Hospitals
12.10.3 Home Use
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibody Tests
13.6.2 RNA (viral load) Test
13.6.3 Antibody-antigen Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostic Centers
13.10.2 Hospitals
13.10.3 Home Use
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 AIDS Test Kits Market: Competitive Dashboard
14.2 Global AIDS Test Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Abbott
14.3.3 Bio-Rad
14.3.4 WanTai BioPharm
14.3.5 Beckman Coulter
14.3.6 BD
14.3.7 Kehua
14.3.8 Livzon
14.3.9 Intec
14.3.10 ThermoFisher
14.3.11 Biokit
14.3.12 Nectar Lifesciences
14.3.13 ELITech Group
14.3.14 Chembio Diagnostic Systems
14.3.15 Trinity Biotech
